Form 4 for RH RH
Accepted 2025-01-22 00:00:00 ET · period of report 2025-01-21 · accession 0001415889-25-001890 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-01-22 | 2025-01-21 | RH | Chaya Eri | SEE REMARKS, Dir | M - OptEx | $39.42 | +25.0K | 25.0K | New | +$985.5K |
| DM | 2025-01-22 | 2025-01-21 | RH | Chaya Eri | SEE REMARKS, Dir | S - Sale+OE | $450.45 | -25.0K | 3,130 | -89% | -$11.26M |
| D | 2025-01-22 | 2025-01-21 | RH | Chaya Eri | SEE REMARKS, Dir | M - OptEx | $0.00 | -25.0K | 50.0K | -33% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-21 | M | A | 25,000 | $39.42 | 25,000 | D | — | — | |
| 2 | Common | Common Stock | 2025-01-21 | S | D | 245 | $452.55 | 569 | D | — | — | (F4) This transaction was executed in multiple trades ranging from $452.19 to $453.07. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. (F1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 7, 2024. |
| 3 | Common | Common Stock | 2025-01-21 | S | D | 335 | $453.74 | 234 | D | — | — | (F5) This transaction was executed in multiple trades ranging from $453.46 to $454.21. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. (F1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 7, 2024. |
| 4 | Common | Common Stock | 2025-01-21 | S | D | 234 | $454.62 | 0 | D | — | — | (F1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 7, 2024. (F6) This transaction was executed in multiple trades ranging from $454.57 to $454.78. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. |
| 5 | Common | Common Stock | 2025-01-21 | S | D | 2,316 | $451.56 | 814 | D | — | — | (F3) This transaction was executed in multiple trades ranging from $451.06 to $452.01. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. (F1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 7, 2024. |
| 6 | Common | Common Stock | 2025-01-21 | S | D | 21,870 | $450.21 | 3,130 | D | — | — | (F2) This transaction was executed in multiple trades ranging from $450.00 to $450.95. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price within the range set forth herein. (F1) The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on October 7, 2024. |
| 7 | Derivative | Stock Option (Right to Buy) | 2025-01-21 | M | D | 25,000 | $0.00 | 50,000 | D | $39.42 · — to 2026-05-03 | 25,000 Common Stock | (F8) This option award is fully vested and exercisable. |